With 1.78 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.3 million shares. The 52-week range on EXEL shows that it touched its highest point at $37.59 and its lowest point at $20.14 during that stretch. It currently has a 1-year price target of $37.00. Beta for the stock currently stands at 0.60.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EXEL was up-trending over the past week, with a rise of 6.98%, but this was down by -3.68% over a month. Three-month performance surged to 1.86% while six-month performance rose 31.97%. The stock gained 71.34% in the past year, while it has gained 5.38% so far this year. A look at the trailing 12-month EPS for EXEL yields 1.77 with Next year EPS estimates of 2.35. For the next quarter, that number is 0.38. This implies an EPS growth rate of 14.97% for this year and 16.21% for next year. EPS is expected to grow by 20.17% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 11.55%.
Float and Shares Shorts:
At present, 281.73 million EXEL shares are outstanding with a float of 272.08 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for EXEL since 8 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.67424 being high and $0.48775 being low. For EXEL, this leads to a yearly average estimate of $0.61686. Based on analyst estimates, the high estimate for the next quarter is $0.64 and the low estimate is $0.48. The average estimate for the next quarter is thus $0.56.
